These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20188200)

  • 1. A high-throughput colorimetric-based bioassay method for determination of fosmidomycin in plasma and urine and application for pharmacokinetic study.
    Cheoymang A; Na-Bangchang K
    J Pharmacol Toxicol Methods; 2010; 61(3):346-50. PubMed ID: 20188200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioassay for determination of fosmidomycin in plasma and urine: application for pharmacokinetic dose optimisation.
    Cheoymang A; Hudchinton D; Kioy D; Na-Bangchang K
    J Microbiol Methods; 2007 Apr; 69(1):65-9. PubMed ID: 17258829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative liquid chromatography-mass spectrometric method for the determination of azithromycin in human plasma and its application to pharmacokinetic study of patients with malaria.
    Choemunng A; Na-Bangchang K
    Southeast Asian J Trop Med Public Health; 2010 Sep; 41(5):1048-58. PubMed ID: 21073024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative high-performance liquid chromatographic method for determination of clindamycin in plasma.
    Na-Bangchang K; Banmairuroi V; Kamanikom B; Kiod D
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):177-84. PubMed ID: 16771232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of fosmidomycin in human serum and urine by capillary electrophoresis.
    Bronner S; Renault C; Hintz M; Wiesner J; Jomaa H; Monteil H; Jehl F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):255-61. PubMed ID: 15171936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria.
    Na-Bangchang K; Ruengweerayut R; Karbwang J; Chauemung A; Hutchinson D
    Malar J; 2007 May; 6():70. PubMed ID: 17531088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic method for the determination of ivermectin in plasma.
    Na-Bangchang K; Banmairuroi V; Choemung A
    Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):848-58. PubMed ID: 17333725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria.
    Ruangweerayut R; Looareesuwan S; Hutchinson D; Chauemung A; Banmairuroi V; Na-Bangchang K
    Malar J; 2008 Oct; 7():225. PubMed ID: 18973702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-performance liquid chromatographic method for determination of praziquantel in plasma.
    Hanpitakpong W; Banmairuroi V; Kamanikom B; Choemung A; Na-Bangchang K
    J Pharm Biomed Anal; 2004 Nov; 36(4):871-6. PubMed ID: 15533682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic method for determination of 2-difluoromethyl-DL-ornithine in plasma and cerebrospinal fluid.
    Hanpitakpong W; Kamanikom B; Banmairuroi V; Na-Bangchang K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(2):221-31. PubMed ID: 12705962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives.
    Bergan T
    Chemotherapy; 1990; 36 Suppl 1():10-8. PubMed ID: 2085981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria.
    Borrmann S; Adegnika AA; Moussavou F; Oyakhirome S; Esser G; Matsiegui PB; Ramharter M; Lundgren I; Kombila M; Issifou S; Hutchinson D; Wiesner J; Jomaa H; Kremsner PG
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3749-54. PubMed ID: 16127049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic evaluation of fosmidomycin, a new phosphonic acid antibiotic.
    Kuemmerle HP; Murakawa T; De Santis F
    Chemioterapia; 1987 Apr; 6(2):113-9. PubMed ID: 3594633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of sofalcone in human plasma and urine by high performance liquid chromatography-mass spectrometry.
    Wang L; Song L; Jiang X
    J Pharm Biomed Anal; 2011 Jul; 55(5):1179-85. PubMed ID: 21530127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosmidomycin: a new phosphonic acid antibiotic. Part I: Phase I tolerance studies.
    Kuemmerle HP; Murakawa T; Soneoka K; Konishi T
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):515-20. PubMed ID: 4066075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies.
    Kuemmerle HP; Murakawa T; Sakamoto H; Sato N; Konishi T; De Santis F
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):521-8. PubMed ID: 4066076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and selective liquid chromatographic/tandem mass spectrometric method for the determination of fosfomycin in human plasma.
    Li L; Chen X; Dai X; Chen H; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):171-7. PubMed ID: 17574936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children.
    Borrmann S; Adegnika AA; Matsiegui PB; Issifou S; Schindler A; Mawili-Mboumba DP; Baranek T; Wiesner J; Jomaa H; Kremsner PG
    J Infect Dis; 2004 Mar; 189(5):901-8. PubMed ID: 14976608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria.
    Borrmann S; Issifou S; Esser G; Adegnika AA; Ramharter M; Matsiegui PB; Oyakhirome S; Mawili-Mboumba DP; Missinou MA; Kun JF; Jomaa H; Kremsner PG
    J Infect Dis; 2004 Nov; 190(9):1534-40. PubMed ID: 15478056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Tahar R; Basco LK
    Am J Trop Med Hyg; 2007 Aug; 77(2):214-20. PubMed ID: 17690389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.